Published Date: 16 Feb 2023
Although there are concerns that the use of Paxlovid increases the risk of COVID-19 returning, the results are clear.
Read Full News1.
FINAL USPSTF RECOMMENDATIONS ON ANXIETY, DEPRESSION, AND SUIICIDAL RISK.
2.
Can Alternating Venetoclax Regimens Improve AML Outcomes?
3.
Advanced imaging, targeted therapy help men with prostate cancer safely defer surgery and radiation therapy
4.
C/EBP? works in tandem with MYB to sustain AML cells' oncogenic program.
5.
WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research
1.
Targeting Oncology: Expanding Combinatorial Strategies by 2025
2.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
3.
Exosomes in Cancer: A Novel Frontier for Therapy and Biomarker Discovery
4.
Cancer Care Advances: Metformin, Digital Tools, and Artificial Renal Support
5.
Hematologic Cytomorphology: From Microscopy to Molecular Diagnostics
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III
4.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
5.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation